Conserved SARS-CoV-2 T cell epitope proteins

"Conserved SARS-CoV-2 T cell epitope proteins" collectively refers to the structural (e.g., spike, membrane, envelope, nucleocapsid) and non-structural proteins (e.g., nsp3, nsp12, ORF3, ORF8) of the SARS-CoV-2 virus that contain peptide regions (epitopes) consistently recognized by human T cells[1][2][4]. These epitopes, when conserved across viral variants, are crucial targets for eliciting robust T cell responses in both natural infection and vaccination, providing protective immunity and forming the basis for immune monitoring. Most current vaccines aim to present such conserved regions to maximize cross-reactive, variant-resistant T cell immunity. Unlike a single receptor, these proteins are sources of multiple short peptide antigens presented by MHC class I or II molecules to stimulate SARS-CoV-2-specific T cell immunity, contributing to viral clearance, disease control, and long-term immune memory[1][2][3][4][5].

Other names

SARS-CoV-2 T cell epitope proteinsSARS-CoV-2 immunodominant T cell epitopesSARS-CoV-2 conserved T cell regions

Immune stimulation (via vaccination or infection, these epitopes provoke T cell responses); Antigen presentation (fragments loaded onto MHC molecules stimulate T cells)